[{"address1": "200 Minuteman Road", "address2": "Suite 302", "city": "Andover", "state": "MA", "zip": "01810", "country": "United States", "phone": "978 552 0900", "website": "https://www.transmedics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.", "fullTimeEmployees": 584, "companyOfficers": [{"maxAge": 1, "name": "Dr. Waleed H. Hassanein M.D.", "age": 55, "title": "Founder, President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1817496, "exercisedValue": 13381959, "unexercisedValue": 45252580}, {"maxAge": 1, "name": "Mr. Stephen  Gordon", "age": 55, "title": "CFO, Treasurer & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 909615, "exercisedValue": 1305500, "unexercisedValue": 3853568}, {"maxAge": 1, "name": "Mr. Nicholas  Corcoran", "age": 40, "title": "Senior Vice President of Supply Chain & Operations", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 812071, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anil  Ranganath", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "totalPay": 561674, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamer I. Khayal M.D.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 900108, "exercisedValue": 5450721, "unexercisedValue": 5052497}, {"maxAge": 1, "name": "Ms. Miriam C. Provost Ph.D.", "age": 62, "title": "Vice President of Global Regulatory Affairs", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 535930, "exercisedValue": 390248, "unexercisedValue": 1664774}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 122.94, "open": 122.13, "dayLow": 116.58, "dayHigh": 123.33, "regularMarketPreviousClose": 122.94, "regularMarketOpen": 122.13, "regularMarketDayLow": 116.58, "regularMarketDayHigh": 123.33, "beta": 1.986, "trailingPE": 2966.5002, "forwardPE": 62.125656, "volume": 1365434, "regularMarketVolume": 1365434, "averageVolume": 1044292, "averageVolume10days": 866740, "averageDailyVolume10Day": 866740, "marketCap": 3953074944, "fiftyTwoWeekLow": 36.42, "fiftyTwoWeekHigh": 177.37, "priceToSalesTrailing12Months": 11.018747, "fiftyDayAverage": 151.0221, "twoHundredDayAverage": 121.47065, "currency": "USD", "enterpriseValue": 4254942208, "profitMargins": 0.00836, "floatShares": 32328892, "sharesOutstanding": 33314300, "sharesShort": 6016782, "sharesShortPriorMonth": 5871302, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.18059999, "heldPercentInsiders": 0.03196, "heldPercentInstitutions": 1.07977, "shortRatio": 4.39, "shortPercentOfFloat": 0.22, "impliedSharesOutstanding": 33551300, "bookValue": 5.7, "priceToBook": 20.817545, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 3000000, "trailingEps": 0.04, "forwardEps": 1.91, "enterpriseToRevenue": 11.86, "enterpriseToEbitda": 99.396, "52WeekChange": 2.084295, "SandP52WeekChange": 0.3975451, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TMDX", "underlyingSymbol": "TMDX", "shortName": "TransMedics Group, Inc.", "longName": "TransMedics Group, Inc.", "firstTradeDateEpochUtc": 1556803800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "92140e2a-40a2-3a8f-af5f-f1195b90106c", "messageBoardId": "finmb_429233", "gmtOffSetMilliseconds": -14400000, "currentPrice": 118.66, "targetHighPrice": 208.0, "targetLowPrice": 153.0, "targetMeanPrice": 183.0, "targetMedianPrice": 179.5, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 362751008, "totalCashPerShare": 10.874, "ebitda": 42808000, "totalDebt": 516492992, "quickRatio": 8.171, "currentRatio": 9.374, "totalRevenue": 358759008, "debtToEquity": 271.99, "revenuePerShare": 10.943, "returnOnAssets": 0.02451, "returnOnEquity": 0.0179, "freeCashflow": -240133376, "operatingCashflow": 23719000, "revenueGrowth": 1.179, "grossMargins": 0.60712004, "ebitdaMargins": 0.119320005, "operatingMargins": 0.10943, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-23"}]